COL1A2 and gastric cancer: Clinical analysis of this study strongly indicated that ECM components (ITGB1, COL1A1, COL1A2, COL4A1, FN1, COL6A3, and THBS2) in GC were significantly correlated with overexpression and poor prognosis.